EP3579826
METHODS OF TREATING CDKL5 DISORDERS WITH THE COMPOUND OV329
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
8.2.2018EP published:
7.1.2026EP application number:
18752026.7
EPO information:
European Patent Register
Max expiry date:
7.2.2038Expiry date:
6.5.2026
Title in English:
METHODS OF TREATING CDKL5 DISORDERS WITH THE COMPOUND OV329Language of the patent:
English
Timeline
Today
8.2.2018EP application
7.1.2026EP Publication
6.5.2026Expires
Owner
Name:
Ovid Therapeutics Inc.Address:
441 9th Avenue, 14th Floor, New York, NY 10001, US
Inventor
Name:
DURING, MatthewAddress:
Weston, Connecticut 06883, US
Priority
Number:
201762456320 PDate:
8.2.2017Country:
US
Classification
Categories:
A61K 31/196, A61K 31/185, A61K 31/195, A61K 31/205, A61P 25/08, C07C 229/00, C07C 229/46, C07C 229/48